Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,075.00p
   
  • Change Today:
    -25.00p
  • 52 Week High: 3,775.00p
  • 52 Week Low: 1,835.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 2,113
  • Market Cap: £108.42m

Latest ShareCast News

China weakness sees profits fall for Bioventix

By Josh White

Date: Monday 27 Oct 2025

(Sharecast News) - Bioventix reported lower annual profits on Monday, as weakness in its core markets, particularly China, offset gains from growing demand for its neurological diagnostic antibodies.

Revenue rises, profit falls for Bioventix

By Josh White

Date: Monday 31 Mar 2025

(Sharecast News) - Bioventix reported a marginal rise in revenue for the six months ended 31 December on Monday, with profit before tax dipping slightly due to higher research and development expenditure.

Director dealings: Bioventix CFO raises stake

By Iain Gilbert

Date: Thursday 31 Oct 2024

(Sharecast News) - Bioventix revealed on Thursday that chief financial officer Bruce Hiscock had acquired 333 ordinary shares in the London-listed antibodies development and supply company.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,075.00p
Change Today -25.00p
% Change -1.19 %
52 Week High 3,775.00p
52 Week Low 1,835.00p
Volume 2,113
Shares Issued 5.22m
Market Cap £108.42m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for 20-Nov-2025

Time Volume / Share Price
16:04 38 @ 2,091.00p
15:50 47 @ 2,091.00p
15:49 181 @ 2,050.00p
15:24 256 @ 2,092.00p
14:33 181 @ 2,075.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page